Company Filing History:
Years Active: 2017
Title: Ian Wigginton: Innovator in PAD4 Inhibition
Introduction
Ian Wigginton is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work focuses on creating innovative solutions for PAD4-related disorders.
Latest Patents
Ian Wigginton holds 1 patent for his invention titled "Aza-benzimidazole inhibitors of PAD4." This patent provides compounds that are useful as inhibitors of PAD4, along with compositions and methods for treating disorders related to PAD4. His research aims to advance therapeutic options for patients suffering from these conditions.
Career Highlights
Wigginton is currently associated with Padlock Therapeutics, Inc., where he continues to explore and develop new therapeutic strategies. His expertise in the field has positioned him as a key player in the ongoing research and development of innovative treatments.
Collaborations
Ian collaborates with talented professionals such as Rajesh Devraj and Gnanasambandam Kumaravel. Together, they work towards advancing the understanding and treatment of PAD4-related disorders.
Conclusion
Ian Wigginton's contributions to the field of medicinal chemistry and his innovative patent on PAD4 inhibitors highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of complex disorders.